| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $889K | -0.3% | +47.7% |
| R&D Expense | $58.9M | -15.7% | -28.3% |
| SG&A Expense | $16.9M | -10.5% | -2.8% |
| Operating Income | -$132.1M | +42.4% | -19.9% |
| Pre-tax Income | -$105.8M | +48.9% | -24.4% |
| Income Tax | $619K | -52.1% | -29.3% |
| Net Income | -$106.4M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $286.5M | +48.0% | +27.0% |
| Short-term Investments | $1.63B | +6.7% | -4.7% |
| Accounts Receivable | $0 | — | — |
| Current Assets | $1.93B | +11.3% | -0.8% |
| Total Assets | $2.25B | +10.6% | -0.5% |
| Current Liabilities | $119.0M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$252.5M | — | — |
| Capital Expenditures | $397K | — | — |
| Investing Cash Flow | -$69.0M | — | — |
| Financing Cash Flow | $309.6M | — | — |
| Free Cash Flow | -$252.9M | — | — |
| +49.0% |
| -23.9% |
| EPS (Basic) | -$1.17 | +51.3% | -15.8% |
| EPS (Diluted) | -$1.17 | +51.3% | -15.8% |
| +14.0% |
| +32.5% |
| Total Liabilities | $329.3M | +3.4% | +4.1% |
| Stockholders' Equity | $1.92B | +12.0% | -1.2% |